Olsson, Linnea T. http://orcid.org/0000-0002-2786-5966
Hamilton, Alina M.
Van Alsten, Sarah C.
Lund, Jennifer L.
Stürmer, Til
Nichols, Hazel B.
Reeder-Hayes, Katherine E.
Troester, Melissa A.
Funding for this research was provided by:
National Cancer Institute (P01 CA151135, P50 CA058223, U54 CA156733, R01 CA253450)
Susan G. Komen (OGUNC1202, TREND21686258, SAC210102)
Article History
Received: 17 July 2023
Accepted: 22 October 2023
First Online: 9 December 2023
Declarations
:
: Dr. Reeder-Hayes has received research funding from Pfizer Global Medical Foundation. Dr. Stürmer receives salary support as Director of Comparative Effectiveness Research (CER), NC TraCS Institute, UNC Clinical and Translational Science Award (UL1TR002489), the Center for Pharmacoepidemiology (current members: GlaxoSmithKline, UCB BioSciences, Takeda, AbbVie, Boehringer Ingelheim), from pharmaceutical companies (Novo Nordisk), and from a generous contribution from Dr. Nancy A. Dreyer to the Department of Epidemiology, University of North Carolina at Chapel Hill. Dr. Stürmer does not accept personal compensation of any kind from any pharmaceutical company. He owns stock in Novartis, Roche, and Novo Nordisk. Other authors report no financial or non-financial interests.